Équipe K.HNIA

Karim HNIA

INSERM researcher

He develops research programs on how PI-metabolism regulate proteostasis in skeletal muscle and implications in muscle diseases such as myopathies and sarcopenia.

Career path
Master and PhD degrees in biochemistry and molecular biology at university of Montpellier (2002-2006), Postdoc position IGBMC, Strasbourg (2007-2011), junior researcher at the IGBMC (2012) and senior researcher at the I2MC (2016-current)..

Main domains of expertise
Phosphoinositides, proteostasis, trafficking, muscle disease and physiology.

Marie VANDROMME

INSERM researcher

Her current research focuses on the contribution of epigenetic mechanisms to the etiology of X-linked myotubular myopathy, a fatal pediatric disease due to mutations in the gene encoding the phosphoinositide 3-phosphatase MTM1.

Career path

Master’s degree and PhD in Biology&Health at University of Montpellier, France. HDR (University Paul Sabatier. 1995-1997 post-doctoral period at the National Institute for Medical Research, London (England). 1995-current INSERM researcher at the CRBM and IGH, Montpellier (1995-1999), at ENS Lyon (2000-2003), LBCMCP and CBI, Toulouse (2004-august 2021), and I2MC (September 2021-current).

Main domains of expertise

Proliferation and differentiation, skeletal muscle, Cancer, Myopathy, Chromatin, Histone modifications and gene expression, Transcription, Cell and molecular biology.

Mathilde VAUCOURT

PhD Student

Nesrine HIFDI

PhD Student

Marine MARSEILLAC

Engineer

Marine Marseillac is working on the characterization of new PI3Ks inhibitors in different in vitro cellular models.

Career path

Master’s degree in Biology-Health with a specialization in Physiopathology at Paul Sabatier University, Toulouse.

Main domains of expertise

Cellular biology, Molecular biology, Biochemistry.